Group One Trading
LTRN icon

Group One Trading’s Lantern Pharma LTRN Stock Holding History

Group One Trading’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32 Sell
23
-4,049
-99% -$11.3K ﹤0.01% 7456
2025
Q4 		$12.3K Sell
4,072
-1,000
-20% -$3.72K ﹤0.01% 6685
2025
Q3 		$22.1K Buy
5,072
+2,100
+71% +$8.77K ﹤0.01% 6625
2025
Q2 		$9.39K Buy
+2,972
New +$10K ﹤0.01% 6758

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's LTRN Position: Q1 2026 in Review

Group One Trading reduced its Lantern Pharma (LTRN) stake by 99% in Q1 2026, selling an estimated $11.3K and leaving 23 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #7456.

Group One Trading first reported a position in LTRN in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.1K in Q3 2025. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Group One Trading held 23 shares of Lantern Pharma worth $32 as of Q1 2026.
  • Group One Trading sold 4,049 Lantern Pharma shares in Q1 2026, an estimated $11.3K.
  • Lantern Pharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7456 holding.
  • Group One Trading first reported a position in Lantern Pharma in Q2 2025 and has held it in 4 quarters since.
  • Group One Trading's Lantern Pharma position peaked at $22.1K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.